Brief: Selecta Biosciences Reports Third Quarter Financial Results

Cartesian Therapeutics

03/11/2022 12:32

Nov 3 (Reuters) - Selecta Biosciences Inc  SELB.O :
    * SELECTA BIOSCIENCES REPORTS THIRD QUARTER 2022 FINANCIAL
RESULTS
AND PROVIDES BUSINESS UPDATE
    * SELECTA - CASH, CASH EQUIVALENTS, RESTRICTED CASH &
MARKETABLE
SECURITIES, AS OF SEPT 30, 2022, EXPECTED TO PROVIDE RUNWAY INTO
MID-2024
    * QTRLY LOSS PER SHARE $0.05
    * Q3 EARNINGS PER SHARE VIEW $-0.01 -- REFINITIV IBES DATA

Source text for Eikon:  ID:nGNX3fhcrB 
Further company coverage:  SELB.O 
 ((reuters.briefs@thomsonreuters.com;))